Skip to content
Close
SEARCH
CONTACT US
CONTACT US

OUR SERVICES

We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.

VIEW ALL SERVICES
PHASES
DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
CLINICAL DEVELOPMENT
Advance through clinical
development and health
authority review with confidence.
ALL STAGES
Benefit from our expertise
across all phases
of drug development.
PRECLINICAL
Navigate the critical
preclinical testing phase
with expert guidance.
COMMERCIALIZATION
Successfully bring your
product to market with
our commercialization support.
ALL SERVICES
Access comprehensive
services for every stage
of product development.

ABOUT US

We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.

LEARN MORE ABOUT US
EXPERTISE WITH PERSONALITY
OUR FOUNDER
Discover the visionary
leader driving Halloran's
success and innovation.
STRATEGIC PARTNERS
Meet our trusted
strategic partners who
enhance our capabilities.
WHY HALLORAN?
Explore the unique reasons
why clients choose
Halloran for their needs.
OUR TEAM
Get to know the dedicated
professionals who make
up the Halloran team.
CAREERS
Join our dynamic team
and advance your
career with Halloran.
CASE STUDIES
Learn Halloran’s unique
strategy and approach to address
the pressing needs of our clients.
hcg-service-hero-1

Insights From Halloran

Carolina Ahrendt, MBA, PMPApr 10, 2025 12:40:26 PM6 min read

Ticking Timeline: Tips for Effective Product Development Timelines

Once a biotech or pharmaceutical company defines their product development objectives ...
Start Reading
Kanchana IyerApr 3, 2025 10:30:00 AM3 min read

Navigating Drug, Biologic and Medical Device Regulatory Strategies

Contributing Author: Mamta Puri-Lechner In a recent webinar, Kanchana Iyer and Mamta ...
Start Reading
Daniel SmithMar 12, 2025 10:21:13 AM1 min read

FDA Announces Key Transition Dates for ESG NexGen

Halloran participated in the User Acceptance Testing last summer/fall and is excited ...
Start Reading
Pamela VizankoMar 4, 2025 4:00:00 PM3 min read

Pathway to Success: How De-Risking Life Sciences Companies Leads to Investment Growth

Biocom California hosted the Global Life Science Partnering and Investor Conference in ...
Start Reading
Meghan Patterson, MPHFeb 26, 2025 9:30:00 AM3 min read

Empowering Success in Small Pharma and Biotech for Optimal Results

Optimize budgets and teams to achieve efficiencies without compromising quality in small ...
Start Reading
Halloran Consulting GroupFeb 3, 2025 3:31:27 PM3 min read

Preparing Your Life Sciences Company for 2025

The 43rd Annual Healthcare Conference took place, January 13-16, 2025, in San Francisco, ...
Start Reading
Halloran Consulting GroupJan 9, 2025 12:00:00 AM< 1 min read

Groundbreaking Rare Disease Drug Approval (OGSIVEO [nirogacestat]) Propelled by Expert Regulatory Strategy and Program Management

Rare Disease Drug Approval (OGSIVEO [nirogacestat]) SpringWorks Therapeutics, a ...
Start Reading
Halloran Consulting GroupDec 31, 2024 12:00:00 AM4 min read

Successfully Managing the Transition from Research to Development

The journey from research to development is one of the most critical phases in drug ...
Start Reading
Halloran Consulting GroupDec 17, 2024 7:12:38 PM4 min read

The Butterfly Effect in Clinical Trials: Enhancing Study Quality Through Effective Training

What is The Butterfly Effect?
Start Reading
Halloran Consulting GroupDec 16, 2024 12:00:00 AM2 min read

Three Ways to Accelerate from Trial to Market

Start Reading
Load more posts